Recent News

• 04.14.2025 - 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.10.2025 - CORRESP - Correspondence
• 04.10.2025 - UPLOAD - SEC-generated letter
• 04.04.2025 - 8-K - Current report
• 03.14.2025 - 424B3 - Prospectus [Rule 424(b)(3)]
• 03.14.2025 - EFFECT - Notice of Effectiveness
• 03.07.2025 - D - Notice of Exempt Offering of Securities
• 03.06.2025 - S-3 - Registration statement under Securities Act of 1933
• 03.04.2025 - GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
• 02.26.2025 - 8-K - Current report

Recent Filings

• 04.14.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.04.2025 - 8-K Current report
• 03.14.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 03.13.2025 - EFFECT Notice of Effectiveness
• 03.11.2025 - UPLOAD SEC-generated letter
• 03.11.2025 - CORRESP Correspondence
• 03.07.2025 - D Notice of Exempt Offering of Securities
• 03.06.2025 - S-3 Registration statement under Securities Act of 1933
• 02.26.2025 - 8-K Current report